Navigation Links
Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
Date:6/22/2009

SEATTLE, June 22 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY) (the "Company") today announced that Merck KGaA of Darmstadt, Germany, has initiated a global Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine, L-BLP25) in patients with hormone receptor-positive, locally advanced, recurrent or metastatic breast cancer. Stimuvax is an investigational therapeutic cancer vaccine being developed by Merck KGaA under a license agreement with Oncothyreon.

The Phase 3 trial, named STRIDE (STimulating immune Response In aDvanced brEast cancer), is anticipated to enroll more than 900 patients at approximately 180 sites in over 30 countries - including North America, Europe, Asia and Australia. Patients with estrogen receptor-positive and/or progesterone receptor-positive, non-resectable locally advanced, recurrent or metastatic breast cancer receiving hormonal therapy will be randomized to receive either Stimuvax or a placebo in a 2:1 ratio. The primary endpoint of STRIDE is progression-free survival. Overall survival, quality of life, tumor response and safety will also be assessed in this study.

"Advanced-stage breast cancer remains a devastating and challenging disease and we urgently need new treatment options," said Dr. Larry Shulman, Chief Medical Officer and Senior Vice President for Medical Affairs, Dana-Farber Cancer Institute, Boston, Massachusetts, and Principal Investigator of STRIDE. "If the results from the Phase 3 STRIDE study prove positive, this could make a difference for patients with hormone receptor positive metastatic breast cancer."

"The initiation of the STRIDE study is an enormous step forward in clinical breast cancer research and represents our continued commitment to developing Stimuvax within a robust clinical trial program across several cancer types. We are very excited that Stimuvax will now be test
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
2. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Oncothyreon announces closing of $11.1 million registered direct financing
4. Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
5. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
6. Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Oncothyreon reports first quarter 2009 financial results
8. Oncothyreon regains compliance with NASDAQ listing requirements
9. Oncothyreon to present at Invest Northwest 2009
10. Oncothyreon reports full year and fourth quarter 2008 financial results
11. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , ROCKVILLE, Md., Nov. 20 /PRNewswire-... announced that it has priced an underwritten publ...k at a price to the public of $3.30 per share. Th... deducting the underwriting discounts and commissi...ical trials of our VLP-based vaccines, internal re...
(Date:11/19/2009)..., , Most people would like to be able to charge t...ickly and not too often. A recent discovery made b...tube-based supercapacitors that could do just this...hysics Letters , Prabhakar Bandaru, a professor in...ngineering, along with graduate student Mark Hoefe...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCal...today that it has sent the following letter to its...n, on October 30, 2009, of China Biopharmaceutical...eutical company based in the People,s Republic of ...interest in Suzhou Eyre Pharmaceutical Co. Ltd., C...
(Date:11/19/2009)..., Top LASIK surgeons and ... listed at Trusted LASIK Surgeons made brought the...pments in vision correction surgery, cataract surg...concluded American Academy of Ophthalmology (AAO) ...ichard Lindstrom, Dr. Shachar Tauber, Dr. David Hu...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Nanotube defects equal better energy and storage systems 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...ct. 21 Canary Foundation, a,nonprofit organizatio...nounced that its Scientific Program Director, Dr. ...er of the U.S. National Academies Institute of,Med...the fields of health,and medicine. The IOM, establ... serves as adviser to the nation to improve health...
...roduction, Increased Bioavailability, MOUNTAIN VI...es that are either incurable or difficult to treat...herapy. Highly prized, due to their,therapeutic po... a wide,variety of diseases. Stem cell research pr...bryonic stem cells have their own unique challenge...
...at NanoBio,s nanoemulsion technology is effective ...and vaccines, ANN ARBOR, Mich., Oct. 21 NanoBio ...ompelling new data in nine presentations that,deta...development programs,in onychomycosis, herpes labi... vaccine during the joint meeting of the Interscie...
Other Biology Technology:Canary Foundation's Dr. Sanjiv Sam Gambhir Elected to the National Academies Institute of Medicine 2Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan 2Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan 3NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008 2
(Date:11/20/2009)...ess an ingenious mechanism for preventing oxygen f...is the new finding of a team of biologists that in...rch institute in Flanders, Belgium, connected to t... this discovery by modifying the DNA of the intest...s model organism, they have uncovered the existenc...
(Date:11/20/2009)...), a respiratory disease commonly known as chronic...use of death worldwide. 600 million people live w...y real treatment or cure, Grace Parraga of Robarts...ntario in London, Canada, is using various imaging... , Parraga is a scientist in the Imaging Rese...
(Date:11/19/2009)...ith an unwieldy name: 4-hydroxybutyrate (4-HB). Ta...ape drug. , Now, a team of Ohio and Michigan sc...is metabolized by the body. "This is new and impor...or and chair of biological sciences at Michigan Te...h team. "It may provide new clues on how to count...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Tumor suppressor gene in flies may provide insights for human brain tumors 8948 1Tumor suppressor gene in flies may provide insights for human brain tumors 8948 2Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate 49621 1Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate 49621 2Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate 49621 3Dismantling Roe v Wade Would Affect All Pregnant Women 49618 1Dismantling Roe v Wade Would Affect All Pregnant Women 49618 2Dismantling Roe v Wade Would Affect All Pregnant Women 49618 3
...NA that helps bacteria commonly found in US meat a...n found in the plague bacillus Yersinia pestis, ge... resist many of the antibiotics used against plagu...he disease in Madagascar. But because the same abi...broad range of livestock, antibiotic resistance co...
... strains of human papillomavirus responsible for m...lar assay uses a cervical scraping, like that for ... and 18, responsible for 70 percent of cervical ca...hysician and director of the Gynecologic Cancer Pr... , “Data from a National Cancer Institute trial...
...out the birds and the bees. But apparently when it...and hers ?and the difference is genetic. Species w...ans, for example) get around the fact that males a...omosome genes with a balancing act geneticists cal...ay in the Journal of Biology shows that birds are ...
Other Biology News:Will the plague pathogen become resistant to antibiotics? 2New test for most virulent HPV strains under study 2New test for most virulent HPV strains under study 3Bird sex is something else 2
...™ Protein Precipitation Kit is designed for ...s samples. Proteomics sample analysis is often ham...ch as buffers, salts and detergents in the protein...tions or enzymatic digestion. Additionally, protei...
...ot cell and PowerPac Basic power supply are used f.... The Mini Trans-Blot cell accommodates two 7.5 x ...dular electrode assembly, Bio-Ice cooling unit, bu.... The PowerPac basic power supply, 100-120 and 220...
...eimide activated carrier proteins to simplify the ...leimide Activated Carrier Proteins are commonly us...erobifunctional cross-linker (Sulfo-SMCC). This ac...carrier protein. Thus allowing the maleimide-acti...
Agarose-HR from Ambion
Biology Products: